DAILY MORNING NOTE | 1 November 2023

Singapore stocks closed higher on Tuesday (Oct 31) amid mixed trading in regional markets. The Index rose 0.1% or 3.45 points to close at 3,067.74.Frasers Logistics & Commercial Trust led the index gainers, climbing 3 per cent to close at S$1.04. Other top performers include Venture Corp, which rose 2.5 per cent, and Mapletree Pan Asia Commercial Trust, which climbed 2.3 per cent.

WALL Street stocks advanced on Tuesday for the second straight session, shrugging off early weakness ahead of a Federal Reserve decision. The Dow Jones Industrial Average finished up 0.4 per cent at 33,052.87. S&P 500 gained 0.7 per cent to 4,193.80, while the tech-rich Nasdaq Composite Index advanced 0.5 per cent to 12,851.24.

Top gainers & losers

Factsheets


EVENTS OF THE WEEK

Factsheets


SG

EC World Reit said on Tuesday (Oct 31) that one of its major tenants, China Tobacco, would not be renewing one of its two leases at Hengde Logistics, a warehouse property in EC World Reit’s portfolio. The manager of the Reit said via a bourse filing that the company has decided to discontinue the lease, despite active negotiations with China Tobacco.

Paragon Reit’s gross revenue grew 1.2% to S$215.6 million over the first three quarters of its financial year ended on Sep 30, from S$213.1 million over the same corresponding period last year. In local currency terms, gross revenue for its Singapore increased 2.4% , while its Australia assets’ revenue rose 5.4% over the same period.

CapitaLand Investment has partnered Thai real estate developer Pruksa Holding (PSH) to set up a healthcare and wellness fund to the tune of S$1 billion. The two parties have so far committed a total initial investment of S$350 million to the CapitaLand Wellness Fund (C-Well), which has funds under management of S$1 billion.

Japfa reported a net loss of US$22.7 million for the first nine months ended Sep 30, 2023, reversing from a net profit of US$46.3 million from the same period a year ago. Revenue was down by a marginal 1 per cent year on year to US$3.3 billion for 9M FY2023. This brought loss per share for the period to 1.11 US cents.

US

Pfizer on Tuesday (Oct 31) reported its first quarterly loss since 2019, as demand fell for its Covid products and it recorded a hefty charge mainly from the US government returning millions of doses of its antiviral treatment Paxlovid. The company recorded a US$5.6 billion charge in the third quarter related to Paxlovid and vaccine Comirnaty, most of which was disclosed earlier this month.

Stellantis said the prolonged strikes that curbed output at its North American facilities cost the Jeep maker around 3 billion euros (S$4.36 billion) in revenue. Pre-tax operating profit during the walkout period was negatively impacted by under 750 million euros. It still reported better-than-expected third-quarter revenue, bolstered by stable pricing, improving logistics and robust demand for models such as the electric Jeep Avenger.

BP’s third-quarter profit rebounded from the prior period, but fell short of estimates as weak results in gas marketing offset a strong performance in oil trading. The huge cash inflows have stimulated a spate of dealmaking, with ExxonMobil and Chevron announcing a pair of acquisitions totalling more than US$100 billion over the past month – widening their lead over Europe’s majors.

Samsung Electronics said on Tuesday that its operating profits for the July to September period were down 77.57 per cent from the year before, even as new smartphone releases boosted revenue. The company announced third-quarter operating profits of S$2.32 billion based on strong sales of flagship models in mobile and strong demand for displays.

Prada reported a 10 per cent rise in third quarter revenues on Tuesday (Oct 31) as a strong performance in Asia and Europe helped to compensate for weakness in the Americas. For the first nine months of the year net revenues totalled S$4.8 billion, a rise of 17% at constant exchange rates, with the ready-to-wear category showing the fastest growth and the Miu Miu brand also expanding rapidly.

Shares of Nvidia Corp dropped by nearly 5% to a nearly five-month-low on Tuesday (Oct 31) following a report that the artificial intelligence (AI) giant may be forced to cancel up to US$5 billion worth of advanced chip orders to China in compliance with new US government restrictions.

Source: SGX Masnet, Bloomberg, Channel NewsAsia, Reuters, CNBC, WSJ, The Business Times, PSR


RESEARCH REPORTS

CapitaLand Ascott Trust – Occupancy to trend upwards

Recommendation: Buy (Upgraded), Last Done: S$0.90

Target price: S$1.04, Analyst: Darren Chan

– 3Q23 gross profit rose 13% YoY to reach 103% of pre-COVID 3Q19 levels.

– 3Q23 portfolio RevPAU rose 17% YoY to S$154, reaching 102% of pre-COVID 3Q19 levels on the continued improvement in portfolio occupancy (77% vs 70% in 3Q22) and average daily rates (ADR). We expect effective borrowing cost to rise from 2.4% in 3Q23 to c.3% for FY24e after refinancing all loans due in FY24.

– Upgrade from ACCUMULATE to BUY due to recent share price performance, DDM-TP lowered from S$1.20 to S$1.04. FY23e/FY24e DPU is lowered by 6%/14% after accounting for the higher share base (+9%) from the equity fund-raising exercise, proposed acquisitions, and higher finance costs. CLAS remains our top pick in the sector owing to its mix of stable and growth income and geographical diversification. Growth in RevPAU going forward will come from higher portfolio occupancy. The current share price implies an FY23e/24e dividend yield of 6.6%.

PSR Stocks Coverage

Factsheets

Factsheets


For more information, please visit:

https://www.stocksbnb.com/singapore-stocks-coverage/


Upcoming Webinars

Corporate Insights by ESR – LOGOS REIT

Date & Time: 1 Nov 2023 | 11am – 12pm

Register: https://tinyurl.com/yfhnfy5v


Corporate Insights by Paragon REIT

Date & Time: 2 Nov 2023 | 12pm – 1pm

Register: https://tinyurl.com/35cprdar


Corporate Insights by Manulife US REIT

Date & Time: 3 Nov 2023 | 12pm – 1pm

Register: https://tinyurl.com/msrd3kn2


Corporate Insights by IREIT Global [NEW]

Date & Time: 10 Nov 2023 | 3pm – 4pm

Register: https://tinyurl.com/ycx3u66x


Corporate Insights by Sasseur REIT

Date & Time: 15 Nov 2023 | 12pm – 1pm

Register: https://tinyurl.com/464ndms7


Corporate Insights by Keppel REIT

Date & Time: 16 Nov 2023 | 12pm – 1pm

Register: https://tinyurl.com/bdzcs5jm


Corporate Insights by First REIT

Date & Time: 28 Nov 2023 | 12pm – 1pm

Register: https://tinyurl.com/58ynewt4


POEMS Podcast:

Research Videos

Weekly Market Outlook: META, Alphabet Inc, Spotify, Microsoft, Amazon, UOB, SG Weekly & More!
Date: 30 October 2023
Click here for more on Market Outlook.
Sign up for our webinars here, and be among the first to receive economy and market updates.

PHILLIP RESEARCH IN 3 MINS

Phillip Research in 3 minutes: #29 Keppel Corporation; Initiation
Click here for more on Phillip in 3 mins.

Follow our Socials

Facebook Social Icon Instagram Icon Twitter Social Icon Youtube Social Icon Linkedin Social Icon TikTok Social Icon Spotify Social Icon

Join our Singapore Equity Research Community on POEMS Mobile 3 App for the latest research reports, market updates, insights and more

Click to join!

Disclaimer

The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.

Confidentiality Note

This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com